Back to Journals » Lung Cancer: Targets and Therapy » Volume 3
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,251 | Dovepress* | 9,980+ | 2,818 | 12,798 | |
PubMed Central* | 271 | 79 | 350 | ||
Totals | 10,251 | 2,897 | 13,148 | ||
*Since 18 December 2012 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar